At diagnosis, seven cases were reclassified by the use of NGS: Five as AML with mutated RUNX1, which were AML not otherwise specified (NOS) and two cases of MDS as MN with the germline GATA2 variant (GATA2 deficiency syndrome). This evidence concerns the gene RUNX1 and acute myeloid leukemia.